{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:57:35Z","timestamp":1790013455645,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["OFIRG18nov-0093"],"award-info":[{"award-number":["OFIRG18nov-0093"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["T2EP30223-0010"],"award-info":[{"award-number":["T2EP30223-0010"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["Tier1 NUHSRO\/2022\/070\/T1\/Seed-Mar\/06"],"award-info":[{"award-number":["Tier1 NUHSRO\/2022\/070\/T1\/Seed-Mar\/06"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.molmed.2024.05.016","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T01:56:42Z","timestamp":1718416602000},"page":"1047-1060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lost in translation: challenges of current pharmacotherapy for sarcopenia"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-6383","authenticated-orcid":false,"given":"Shih-Yin","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.05.016_bb0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.molmed.2024.05.016_bb0010","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.4081\/ejtm.2020.9311","article-title":"Muscle hypertrophy and muscle strength: dependent or independent variables? A provocative review","volume":"30","author":"Reggiani","year":"2020","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/gme.0b013e31816f63a3","article-title":"Menopausal status and physical performance in midlife: findings from a British birth cohort study","volume":"15","author":"Cooper","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.molmed.2024.05.016_bb0020","first-page":"3276","article-title":"Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men","volume":"85","author":"van den Beld","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/gerona\/glt285","article-title":"Longitudinal assessment of the menopausal transition, endogenous sex hormones, and perception of physical functioning: the Study of Women's Health Across the Nation","volume":"69","author":"El Khoudary","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.molmed.2024.05.016_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/cs0840095","article-title":"Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy","volume":"84","author":"Phillips","year":"1993","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.molmed.2024.05.016_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00421-005-0078-4","article-title":"Power output, isometric strength and steadiness in the leg muscles of pre- and postmenopausal women; the effects of hormone replacement therapy","volume":"96","author":"Carville","year":"2006","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/aje\/kwh244","article-title":"The effect of menopause on grip and pinch strength: results from the Chicago, Illinois, site of the Study of Women's Health Across the Nation","volume":"160","author":"Kurina","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0045","doi-asserted-by":"crossref","first-page":"M772","DOI":"10.1093\/gerona\/57.12.M772","article-title":"Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women","volume":"57","author":"Iannuzzi-Sucich","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.molmed.2024.05.016_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exger.2018.02.023","article-title":"Human neuromuscular aging: sex differences revealed at the myocellular level","volume":"106","author":"Roberts","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0047-6374(98)00130-4","article-title":"Predictors of skeletal muscle mass in elderly men and women","volume":"107","author":"Baumgartner","year":"1999","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.molmed.2024.05.016_bb0060","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1210\/jc.2009-2680","article-title":"Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study","volume":"95","author":"Krasnoff","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0065","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1172\/JCI117731","article-title":"Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle","volume":"95","author":"Biolo","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.05.016_bb0070","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI118217","article-title":"Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms","volume":"96","author":"Fryburg","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.05.016_bb0075","first-page":"E331","article-title":"Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism","volume":"267","author":"Fryburg","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.molmed.2024.05.016_bb0080","first-page":"E499","article-title":"Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans","volume":"260","author":"Fryburg","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.molmed.2024.05.016_bb0085","first-page":"E864","article-title":"Testosterone injection stimulates net protein synthesis but not tissue amino acid transport","volume":"275","author":"Ferrando","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.molmed.2024.05.016_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0095","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.1152\/ajpendo.00502.2001","article-title":"Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy","volume":"283","author":"Sinha-Hikim","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0100","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamainternmed.2013.6895","article-title":"Trends in androgen prescribing in the United States, 2001 to 2011","volume":"173","author":"Baillargeon","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamainternmed.2018.6505","article-title":"Trends in testosterone prescribing for age-related hypogonadism in men with and without heart disease","volume":"179","author":"Morden","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0110","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","article-title":"Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle","volume":"90","author":"Bhasin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0120","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty","volume":"58","author":"Kenny","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.molmed.2024.05.016_bb0125","first-page":"2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0130","first-page":"583","article-title":"Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men","volume":"102","author":"Storer","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0135","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/me.2010-0138","article-title":"Research resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function","volume":"24","author":"Wyce","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0140","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jcsm.13251","article-title":"Androgen receptor coordinates muscle metabolic and contractile functions","volume":"14","author":"Ghaibour","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.molmed.2024.05.016_bb0145","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2002-0164","article-title":"Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells","volume":"144","author":"Estrada","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2024.05.016_bb0150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1249\/MSS.0b013e318237c5c0","article-title":"Androgens affect myogenesis in vitro and increase local IGF-1 expression","volume":"44","author":"Sculthorpe","year":"2012","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.molmed.2024.05.016_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2010.08.127","article-title":"Testosterone-induced hypertrophy of L6 myoblasts is dependent upon Erk and mTOR","volume":"400","author":"Wu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0160","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1249\/MSS.0b013e31828cf5f3","article-title":"Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy","volume":"45","author":"Basualto-Alarcon","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.molmed.2024.05.016_bb0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0170","doi-asserted-by":"crossref","unstructured":"Saxton, R.A. and Sabatini, D.M. mTOR signaling in growth, metabolism, and disease. Cell 169, 361-371","DOI":"10.1016\/j.cell.2017.03.035"},{"key":"10.1016\/j.molmed.2024.05.016_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ncb1231","article-title":"Atrophy of S6K1(\u2013\/\u2013) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control","volume":"7","author":"Ohanna","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0180","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1172\/JCI77361","article-title":"Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity","volume":"125","author":"Tsai","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.05.016_bb0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1177221","article-title":"Ribosomal protein S6 kinase 1 signaling regulates mammalian life span","volume":"326","author":"Selman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.05.016_bb0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmet.2009.10.008","article-title":"Autophagy is required to maintain muscle mass","volume":"10","author":"Masiero","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2013.03.015","article-title":"Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy","volume":"17","author":"Castets","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0200","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1038\/s41467-020-18140-1","article-title":"The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia","volume":"11","author":"Ham","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0205","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1038\/s41467-022-35547-0","article-title":"Muscle 4EBP1 activation modifies the structure and function of the neuromuscular junction in mice","volume":"13","author":"Ang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jcsm.13121","article-title":"Activation of eIF4E-binding-protein-1 rescues mTORC1-induced sarcopenia by expanding lysosomal degradation capacity","volume":"14","author":"Crombie","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.molmed.2024.05.016_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12943","article-title":"mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism","volume":"18","author":"Tang","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2024.05.016_bb0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10522-013-9432-9","article-title":"Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway","volume":"14","author":"Sandri","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.molmed.2024.05.016_bb0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/acel.12150","article-title":"Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age","volume":"13","author":"Hwee","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2024.05.016_bb0235","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.celrep.2019.06.094","article-title":"A key role for the ubiquitin ligase UBR4 in myofiber hypertrophy in drosophila and mice","volume":"28","author":"Hunt","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.05.016_bb0240","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41467-021-21738-8","article-title":"Antagonistic control of myofiber size and muscle protein quality control by the ubiquitin ligase UBR4 during aging","volume":"12","author":"Hunt","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev-physiol-012422-112116","article-title":"Myostatin: a skeletal muscle chalone","volume":"85","author":"Lee","year":"2023","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0250","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","article-title":"Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis","volume":"23","author":"Rebbapragada","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0255","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","article-title":"Smad2 and 3 transcription factors control muscle mass in adulthood","volume":"296","author":"Sartori","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0260","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/me.2013-1194","article-title":"Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo","volume":"27","author":"Goodman","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0265","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1074\/jbc.M115.680579","article-title":"Smad2\/3 proteins are required for immobilization-induced skeletal muscle atrophy","volume":"291","author":"Tando","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.05.016_bb0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbrc.2021.10.043","article-title":"Smad2 and Smad3 expressed in skeletal muscle promote immobilization-induced bone atrophy in mice","volume":"582","author":"Umezu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0275","doi-asserted-by":"crossref","first-page":"E2353","DOI":"10.1073\/pnas.1206410109","article-title":"Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin\/activin signaling pathway","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.05.016_bb0280","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1073\/pnas.0811129106","article-title":"Muscle hypertrophy driven by myostatin blockade does not require stem\/precursor-cell activity","volume":"106","author":"Amthor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.05.016_bb0285","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.201109091","article-title":"Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin","volume":"197","author":"Winbanks","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0290","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1152\/japplphysiol.00126.2006","article-title":"Contractile properties of EDL and soleus muscles of myostatin-deficient mice","volume":"101","author":"Mendias","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0295","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1152\/japplphysiol.00300.2010","article-title":"Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice","volume":"109","author":"Personius","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0300","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/nu12082401","article-title":"Myostatin as a biomarker of muscle wasting and other pathologies \u2013 state of the art and knowledge gaps","volume":"12","author":"Baczek","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.molmed.2024.05.016_bb0305","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2012-1273","article-title":"Endocrine and clinical correlates of myostatin serum concentration in men \u2013 the STRAMBO study","volume":"97","author":"Szulc","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","article-title":"Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration","volume":"302","author":"Lakshman","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0315","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cmet.2016.05.023","article-title":"Quantification of GDF11 and myostatin in human aging and cardiovascular disease","volume":"23","author":"Schafer","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.05.016_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","article-title":"Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay","volume":"5","author":"Bergen","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.molmed.2024.05.016_bb0325","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000494137","article-title":"Serum myostatin levels are higher in fitter, more active, and non-frail long-term nursing home residents and increase after a physical exercise intervention","volume":"65","author":"Arrieta","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/j.molmed.2024.05.016_bb0330","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.omtm.2020.04.022","article-title":"Myostatin: a circulating biomarker correlating with disease in myotubular myopathy mice and patients","volume":"17","author":"Koch","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.molmed.2024.05.016_bb0335","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.05.016_bb0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/gerona\/glad033","article-title":"Challenges and future prospects of targeting myostatin\/activin a signaling to treat diseases of muscle loss and metabolic dysfunction","volume":"78","author":"Lee","year":"2023","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.molmed.2024.05.016_bb0345","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase ii, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.molmed.2024.05.016_bb0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2024.05.016_bb0355","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biocel.2016.06.012","article-title":"High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state","volume":"78","author":"White","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0365","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/acel.12425","article-title":"Sex- and tissue-specific changes in mTOR signaling with age in C57BL\/6J mice","volume":"15","author":"Baar","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2024.05.016_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2015.02.015","article-title":"Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women","volume":"65","author":"Markofski","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0375","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","article-title":"Targeting the biology of aging with mTOR inhibitors","volume":"3","author":"Mannick","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.molmed.2024.05.016_bb0380","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2024.05.016_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0395","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2666-7568(21)00062-3","article-title":"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials","volume":"2","author":"Mannick","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.molmed.2024.05.016_bb0400","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1073\/pnas.1121113109","article-title":"Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains","volume":"109","author":"Yuan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.05.016_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001455","article-title":"The circadian clock coordinates ribosome biogenesis","volume":"11","author":"Jouffe","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1399-3046.2003.00148.x","article-title":"Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol","volume":"8","author":"Schachter","year":"2004","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.molmed.2024.05.016_bb0415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0091270007312902","article-title":"Pharmacokinetics of sirolimus (rapamycin) in subjects with severe hepatic impairment","volume":"48","author":"Zimmerman","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0420","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16351","article-title":"Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice","volume":"5","author":"Bitto","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2024.05.016_bb0425","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029702","article-title":"Rate coding and the control of muscle force","volume":"7","author":"Enoka","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcp.1030630211","article-title":"The combined effects of exercise and reduced food intake on skeletal muscle fibers","volume":"63","author":"Goldspink","year":"1964","journal-title":"J. Cell. Comp. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0435","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1113\/JP271188","article-title":"Human skeletal muscle fibre contractile properties and proteomic profile: adaptations to 3 weeks of unilateral lower limb suspension and active recovery","volume":"593","author":"Brocca","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CCM.0b013e31822d7c18","article-title":"Muscle atrophy and preferential loss of myosin in prolonged critically ill patients","volume":"40","author":"Derde","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.molmed.2024.05.016_bb0445","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1113\/jphysiol.2003.046276","article-title":"The effect of ageing and immobilization on structure and function of human skeletal muscle fibres","volume":"552","author":"D'Antona","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0450","doi-asserted-by":"crossref","unstructured":"Ikegawa, S. et al. Muscle force per cross-sectional area is inversely related with pennation angle in strength trained athletes. J. Strength Cond. Res. 22, 128-131","DOI":"10.1519\/JSC.0b013e31815f2fd3"},{"key":"10.1016\/j.molmed.2024.05.016_bb0455","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1113\/EP085267","article-title":"Single muscle fibre contractile properties differ between body-builders, power athletes and control subjects","volume":"100","author":"Meijer","year":"2015","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0460","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1113\/jphysiol.2005.101642","article-title":"Skeletal muscle hypertrophy and structure and function of skeletal muscle fibres in male body builders","volume":"570","author":"D'Antona","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215267","article-title":"Muscle fiber hypertrophy in response to 6 weeks of high-volume resistance training in trained young men is largely attributed to sarcoplasmic hypertrophy","volume":"14","author":"Haun","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.05.016_bb0470","first-page":"700","article-title":"Biochemical adaptation of human skeletal muscle to heavy resistance training and immobilization","volume":"43","author":"MacDougall","year":"1977","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"10.1016\/j.molmed.2024.05.016_bb0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pmr.2011.11.014","article-title":"The paradox of muscle hypertrophy in muscular dystrophy","volume":"23","author":"Kornegay","year":"2012","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.molmed.2024.05.016_bb0480","first-page":"62","article-title":"A phase 2 randomized study investigating the efficacy and safety of myostatin antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J. Frailty Aging"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:52:28Z","timestamp":1778615548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1471491424001382"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.05.016","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lost in translation: challenges of current pharmacotherapy for sarcopenia","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}